Wealth Enhancement Advisory Services LLC Sells 499 Shares of CorVel Corp. $CRVL

Wealth Enhancement Advisory Services LLC lowered its holdings in CorVel Corp. (NASDAQ:CRVL) by 3.5% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,846 shares of the business services provider’s stock after selling 499 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in CorVel were worth $1,424,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the company. Gallacher Capital Management LLC grew its stake in CorVel by 50.0% during the second quarter. Gallacher Capital Management LLC now owns 2,999 shares of the business services provider’s stock valued at $308,000 after acquiring an additional 999 shares in the last quarter. Strs Ohio purchased a new position in CorVel during the first quarter valued at approximately $1,030,000. Ellsworth Advisors LLC grew its stake in CorVel by 5.1% during the first quarter. Ellsworth Advisors LLC now owns 7,640 shares of the business services provider’s stock valued at $855,000 after acquiring an additional 371 shares in the last quarter. Jane Street Group LLC grew its stake in CorVel by 194.7% during the first quarter. Jane Street Group LLC now owns 46,920 shares of the business services provider’s stock valued at $5,254,000 after acquiring an additional 31,000 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in CorVel by 5.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 98,570 shares of the business services provider’s stock valued at $11,037,000 after acquiring an additional 4,964 shares in the last quarter. Hedge funds and other institutional investors own 51.36% of the company’s stock.

Insider Buying and Selling at CorVel

In other CorVel news, CFO Brandon O’brien sold 1,764 shares of the company’s stock in a transaction on Monday, September 8th. The shares were sold at an average price of $91.54, for a total value of $161,476.56. Following the completion of the transaction, the chief financial officer directly owned 8,948 shares in the company, valued at approximately $819,099.92. This represents a 16.47% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Maxim Shishin sold 12,000 shares of the company’s stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $89.16, for a total transaction of $1,069,920.00. Following the completion of the transaction, the insider owned 7,050 shares of the company’s stock, valued at $628,578. This trade represents a 62.99% decrease in their ownership of the stock. The disclosure for this sale can be found here. 44.56% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Separately, Wall Street Zen raised shares of CorVel from a “hold” rating to a “buy” rating in a research note on Friday, September 26th.

CorVel Stock Performance

Shares of CorVel stock opened at $77.42 on Wednesday. CorVel Corp. has a 52-week low of $76.76 and a 52-week high of $128.61. The stock has a market capitalization of $3.97 billion, a price-to-earnings ratio of 39.91 and a beta of 0.96. The company has a fifty day moving average of $86.42 and a 200-day moving average of $100.61.

CorVel (NASDAQ:CRVL) last posted its quarterly earnings results on Tuesday, August 5th. The business services provider reported $0.52 EPS for the quarter. CorVel had a net margin of 10.98% and a return on equity of 32.31%.

About CorVel

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.